InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Chaubey Alka. Director active across 1 company, notably Bionano Genomics, Inc.. Aggregated, 10 disclosures have been recorded. History available since 15 February 2023. The latest transaction was disclosed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Chaubey Alka is a declarant linked to Bionano Genomics, Inc., where the listed role is CHIEF MEDICAL OFFICER. She has 10 filings in total, and within the recent sampled filings the most common transaction nature is Retenue fiscale, with buy and sell amounts of €0 over the period from 2023-02-17 to 2026-06-03.